Corstasis Drug Patent Portfolio

Corstasis owns 1 orange book drug protected by 3 US patents Given below is the list of Corstasis's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11123319 Methods And Compositions For Treating Edema Refractory To Oral Diuretics 04 Dec, 2040
Active
US11260038 04 Dec, 2040
Active
US12329731 Methods And Compositions For Treating Edema Refractory To Oral Diuretics 04 Dec, 2040
Active


Given below is the list of recent legal activities going on the following drug patents of Corstasis.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Yr, Small Entity 28 Aug, 2025 US11260038
Recordation of Patent Grant Mailed 24 Jun, 2025 US12329731
Mail Patent eGrant Notification 17 Jun, 2025 US12329731
Email Notification 17 Jun, 2025 US12329731
Patent Issue Date Used in PTA Calculation 17 Jun, 2025 US12329731
Recordation of Patent eGrant 17 Jun, 2025 US12329731
Patent eGrant Notification 17 Jun, 2025 US12329731
Email Notification 05 Jun, 2025 US12329731
Issue Notification Mailed 04 Jun, 2025 US12329731
Dispatch to FDC 14 May, 2025 US12329731
Application Is Considered Ready for Issue 14 May, 2025 US12329731
Issue Fee Payment Received 13 May, 2025 US12329731
Issue Fee Payment Verified 13 May, 2025 US12329731
Mail Notice of Allowance 09 Apr, 2025 US12329731
Notice of Allowance Data Verification Completed 07 Apr, 2025 US12329731


Corstasis's Family Patents


Family Patents



Corstasis Drug List

Given below is the complete list of Corstasis's drugs and the patents protecting them.


1. Enbumyst

Enbumyst is protected by 3 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11123319 Methods And Compositions For Treating Edema Refractory To Oral Diuretics 04 Dec, 2040
(14 years from now)
Active
US11260038 04 Dec, 2040
(14 years from now)
Active
US12329731 Methods And Compositions For Treating Edema Refractory To Oral Diuretics 04 Dec, 2040
(14 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Enbumyst's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List